0001570562-18-000044.txt : 20180531 0001570562-18-000044.hdr.sgml : 20180531 20180531161535 ACCESSION NUMBER: 0001570562-18-000044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180529 FILED AS OF DATE: 20180531 DATE AS OF CHANGE: 20180531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SILVERNAIL LAUREN P CENTRAL INDEX KEY: 0001225755 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38381 FILM NUMBER: 18871770 MAIL ADDRESS: STREET 1: 15279 ALTON PARKWAY STREET 2: SUITE #100 CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evolus, Inc. CENTRAL INDEX KEY: 0001570562 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461385614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 17901 VON KARMAN AVENUE, SUITE 150 CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: (949) 284-4555 MAIL ADDRESS: STREET 1: 17901 VON KARMAN AVENUE, SUITE 150 CITY: IRVINE STATE: CA ZIP: 92614 4 1 wf-form4_152779767553759.xml FORM 4 X0306 4 2018-05-29 0 0001570562 Evolus, Inc. EOLS 0001225755 SILVERNAIL LAUREN P 17901 VON KARMAN AVE, SUITE 150 IRVINE CA 92614 0 1 0 0 See Remarks Common Stock 2018-05-29 4 A 0 30000 0 A 30000 D Stock Option (Right to Buy) 22.44 2018-05-29 4 A 0 200000 0 A 2028-05-29 Common Stock 200000.0 200000 D Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of May 29, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of May 29, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Chief Financial Officer and Executive Vice President, Corporate Development /s/ Jeffrey J. Plumer, as attorney-in-fact for Lauren Silvernail 2018-05-31